6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79720R0055
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center intends to issue solicitation number 36E79720R0055 seeking once-weekly Glucagon-like peptide-1 receptor agonists for the VA, Bureau of Prisons, and Indian Health Service. Offerors must state the exact brand name and National Drug Code of the drug to be supplied. The contract would have an initial one-year period with four one-year option periods. Interested parties should monitor the Federal Business Opportunities website for solicitation amendments and other documents. Questions may be directed to Teresa Hussain by email. The tentative closing date for proposals is July 2, 2020.
There is no set-aside designation. The NAICS code is 325412, covering pharmaceutical preparation manufacturing. The estimated annual requirements are 383,700 units of dulaglutide 0.75mg/0.5ml injection pens packaged in 4-packs or singly, and 536,592 units of semaglutide 1mg/0.75ml injection pens packaged in 2-packs.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0055 for an unrestrictive procurement for once-weekly Glucagon-like peptide-1 receptor agonists (GLP1 agonist) with an FDA approved indication to reduce risk of major cardiovascular outcomes in adults with type 2 diabetes for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0055 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 17, 2020, with a tentative closing date of July 2, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to: Teresa.Hussain@va.gov.
The estimated annual requirements are as follows:
Item Description Size Estimated Annual Requirements
1a
DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN 4 PACK
OR
1
383,700
1b
SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML 1 PACK
AND
2a
DULAGLUTIDE 1.5MG/0.5ML INJ,SOLN,PEN 4 PACK
OR
1
536,592
2b
SEMAGLUTIDE 1MG/0.75ML INJ,SOLN,PEN,1.5ML 2 PACK
Files
| File | Type | Posted |
|---|---|---|
| 36E79720R0055_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists | Award Notice | |
| 6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity